196 related articles for article (PubMed ID: 22132102)
1. Assessment of hypoxia inducible factor levels in cancer cell lines upon hypoxic induction using a novel reporter construct.
Zhou W; Dosey TL; Biechele T; Moon RT; Horwitz MS; Ruohola-Baker H
PLoS One; 2011; 6(11):e27460. PubMed ID: 22132102
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2 regulates HIF-1alpha protein stabilization in hypoxic melanoma cells via the molecular chaperone HSP90.
Trisciuoglio D; Gabellini C; Desideri M; Ziparo E; Zupi G; Del Bufalo D
PLoS One; 2010 Jul; 5(7):e11772. PubMed ID: 20668552
[TBL] [Abstract][Full Text] [Related]
3. Effects of geldanamycin on HIF-1alpha mediated angiogenesis and invasion in prostate cancer cells.
Alqawi O; Moghaddas M; Singh G
Prostate Cancer Prostatic Dis; 2006; 9(2):126-35. PubMed ID: 16432534
[TBL] [Abstract][Full Text] [Related]
4. RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1alpha.
Liu YV; Baek JH; Zhang H; Diez R; Cole RN; Semenza GL
Mol Cell; 2007 Jan; 25(2):207-17. PubMed ID: 17244529
[TBL] [Abstract][Full Text] [Related]
5. Interaction of the PAS B domain with HSP90 accelerates hypoxia-inducible factor-1alpha stabilization.
Katschinski DM; Le L; Schindler SG; Thomas T; Voss AK; Wenger RH
Cell Physiol Biochem; 2004; 14(4-6):351-60. PubMed ID: 15319539
[TBL] [Abstract][Full Text] [Related]
6. Targeting heat shock protein 90 in pancreatic cancer impairs insulin-like growth factor-I receptor signaling, disrupts an interleukin-6/signal-transducer and activator of transcription 3/hypoxia-inducible factor-1alpha autocrine loop, and reduces orthotopic tumor growth.
Lang SA; Moser C; Gaumann A; Klein D; Glockzin G; Popp FC; Dahlke MH; Piso P; Schlitt HJ; Geissler EK; Stoeltzing O
Clin Cancer Res; 2007 Nov; 13(21):6459-68. PubMed ID: 17975158
[TBL] [Abstract][Full Text] [Related]
7. Degradation of HIF-1alpha under hypoxia combined with induction of Hsp90 polyubiquitination in cancer cells by hypericin: a unique cancer therapy.
Barliya T; Mandel M; Livnat T; Weinberger D; Lavie G
PLoS One; 2011; 6(9):e22849. PubMed ID: 21949677
[TBL] [Abstract][Full Text] [Related]
8. C-Terminal HSP90 Inhibitors Block the HIF-1 Hypoxic Response by Degrading HIF-1α through the Oxygen-Dependent Degradation Pathway.
Kataria N; Martinez CA; Kerr B; Zaiter SS; Morgan M; McAlpine SR; Cook KM
Cell Physiol Biochem; 2019; 53(3):480-495. PubMed ID: 31486323
[TBL] [Abstract][Full Text] [Related]
9. Effect of the hsp90 inhibitor geldanamycin on androgen response of prostate cancer under hypoxic conditions.
Suzuki Y; Kondo Y; Hara S; Kimata R; Nishimura T
Int J Urol; 2010 Mar; 17(3):281-5. PubMed ID: 20409220
[TBL] [Abstract][Full Text] [Related]
10. COMMD1 Promotes pVHL and O2-Independent Proteolysis of HIF-1alpha via HSP90/70.
van de Sluis B; Groot AJ; Vermeulen J; van der Wall E; van Diest PJ; Wijmenga C; Klomp LW; Vooijs M
PLoS One; 2009 Oct; 4(10):e7332. PubMed ID: 19802386
[TBL] [Abstract][Full Text] [Related]
11. Induction of the hypoxia-inducible factor system by low levels of heat shock protein 90 inhibitors.
Ibrahim NO; Hahn T; Franke C; Stiehl DP; Wirthner R; Wenger RH; Katschinski DM
Cancer Res; 2005 Dec; 65(23):11094-100. PubMed ID: 16322259
[TBL] [Abstract][Full Text] [Related]
12. JNK1 mediates degradation HIF-1alpha by a VHL-independent mechanism that involves the chaperones Hsp90/Hsp70.
Zhang D; Li J; Costa M; Gao J; Huang C
Cancer Res; 2010 Jan; 70(2):813-23. PubMed ID: 20068160
[TBL] [Abstract][Full Text] [Related]
13. Aryl hydrocarbon nuclear translocator (ARNT) promotes oxygen-independent stabilization of hypoxia-inducible factor-1alpha by modulating an Hsp90-dependent regulatory pathway.
Isaacs JS; Jung YJ; Neckers L
J Biol Chem; 2004 Apr; 279(16):16128-35. PubMed ID: 14764593
[TBL] [Abstract][Full Text] [Related]
14. Heat shock protein 90 is involved in regulation of hypoxia-driven proliferation of embryonic neural stem/progenitor cells.
Xiong L; Zhao T; Huang X; Liu ZH; Zhao H; Li MM; Wu LY; Shu HB; Zhu LL; Fan M
Cell Stress Chaperones; 2009 Mar; 14(2):183-92. PubMed ID: 18726712
[TBL] [Abstract][Full Text] [Related]
15. Oxygen-independent degradation of HIF-alpha via bioengineered VHL tumour suppressor complex.
Sufan RI; Moriyama EH; Mariampillai A; Roche O; Evans AJ; Alajez NM; Vitkin IA; Yang VX; Liu FF; Wilson BC; Ohh M
EMBO Mol Med; 2009 Apr; 1(1):66-78. PubMed ID: 20049704
[TBL] [Abstract][Full Text] [Related]
16. Low dose geldanamycin inhibits hepatocyte growth factor and hypoxia-stimulated invasion of cancer cells.
Koga F; Tsutsumi S; Neckers LM
Cell Cycle; 2007 Jun; 6(11):1393-402. PubMed ID: 17525527
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of heat shock protein 90 impairs epidermal growth factor-mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivo.
Lang SA; Klein D; Moser C; Gaumann A; Glockzin G; Dahlke MH; Dietmaier W; Bolder U; Schlitt HJ; Geissler EK; Stoeltzing O
Mol Cancer Ther; 2007 Mar; 6(3):1123-32. PubMed ID: 17363505
[TBL] [Abstract][Full Text] [Related]
18. A HIF-1α-driven feed-forward loop augments HIF signalling in Hep3B cells by upregulation of ARNT.
Mandl M; Lieberum MK; Depping R
Cell Death Dis; 2016 Jun; 7(6):e2284. PubMed ID: 27362802
[TBL] [Abstract][Full Text] [Related]
19. Hemin, an iron-binding porphyrin, inhibits HIF-1α induction through its binding with heat shock protein 90.
Lee JM; Lee WH; Kay HY; Kim ES; Moon A; Kim SG
Int J Cancer; 2012 Feb; 130(3):716-27. PubMed ID: 21413014
[TBL] [Abstract][Full Text] [Related]
20. Analysis of hypoxia-inducible factor-1alpha accumulation and cell cycle in geldanamycin-treated human cervical carcinoma cells by laser scanning cytometry.
Schwock J; Geddie WR; Hedley DW
Cytometry A; 2005 Dec; 68(2):59-70. PubMed ID: 16228978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
